Document is current

Article History

Received: 4 October 2023

Accepted: 31 October 2023

First Online: 20 November 2023

Declarations

:

: This study was approved at each study site by the corresponding ethics committee or institutional review board. All clinical work was conducted in compliance with current Good Clinical Practices as defined in the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use guidelines, local regulatory requirements, and the Declaration of Helsinki policy statement. All patients enrolled in the trial provided written informed consent prior to trial participation.

: Not applicable.

: Messoud Ashina reports receiving personal fees from AbbVie, Amgen, Eli Lilly, GlaxoSmithKline, Lundbeck, Novartis, Pfizer, and Teva Pharmaceuticals during the conduct of the study. He reported serving as associate editor of <i>Cephalalgia</i>, associate editor of <i>The Journal of Headache and Pain</i>, and associate editor of <i>Brain</i>.Stewart J. Tepper reports grants for research (no personal compensation): Allergan/AbbVie, Amgen, Eli Lilly, Lundbeck, Neurolief, Novartis, Satsuma, Zosano. Consultant and/or Advisory Boards (honoraria): Aeon, Allergan/AbbVie, Alphasights, Amgen, Aruene, Atheneum, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, ClearView Healthcare Partners, ClickTherapeutics, CoolTech, CRG, Decision Resources, Defined Health, DRG, Eli Lilly, ExpertConnect, FCB Health, Fenix, GLG, Guidepoint Global, Health Advances, Health Science Communications, HMP Communications, Impel, Initiatior Pharma, InteractiveForums, Keyquest, Ki Health Partners, Krog and Partners, Lundbeck, M3 Global Research, Magnolia Innovation, MJH Holdings, Miravo Healthcare, Neurofront Therapeutics, Neurolief, Novartis, P Value Communications, Pain Insights, Inc., Palion Medical, Pfizer, Pulmatrix, Putnam Associates, Rehaler, SAI MedPartners, Satsuma, Slingshot Insights, Spherix Global Insights, Strategy Inc., Synapse Medical Communication, System Analytic, Taylor and Francis, Tegus, Teva, Theranica, Tremeau, Trinity Partners, Unity HA, Vial, XOC, Zosano. Salary: Dartmouth-Hitchcock Medical Center and Thomas Jefferson University. CME honoraria: American Academy of Neurology, American Headache Society, Annenberg Center for Health Sciences, Catamount Medical Education, Diamond Headache Clinic, Forefront Collaborative, Haymarket Medical Education, HMP Global, Medical Education Speakers Network, Medical Learning Institute Peerview, Migraine Association of Ireland, Miller Medical Education, National Association for Continuing Education, North American Center for CME, The Ohio State University, Physicians’ Education Resource, PlatformQ Education, Primed, Vindico Medical Education, and WebMD/Medscape. Astrid Gendolla has received honoraria for advisory boards and lectures from Novartis, Lilly, TEVA, Allergan/AbbVie, Mundipharma, Stada Arzneimittel, Grünenthal, Hormosan Pharma, Perfood, Lundbeck, and Pfizer within the past 3 years. Bjørn Sperling, Anders Ettrup and Mette Krog Josiassen are current employees of H. Lundbeck A/S. Bjørn Sperling and Mette Krog Josiassen own stock in H. Lundbeck A/S. Amaal J. Starling has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, eNeura, Everyday Health, Lundbeck, Med-IQ, Medscape, Miller Medical,  Satsuma, and WebMD within the past 3 years.